Insider · CIK 0001998530
Michael King
Files at SABS (SAB Biotherapeutics, Inc.). First filing Nov 30, 2023, latest Nov 30, 2023.
In brief
Michael King files SEC Form 4 as CFO at SABS (SAB Biotherapeutics, Inc.). Since Nov 30, 2023, Michael King has reported 1 open-market buy worth $4,500 and 0 open-market sells worth $0, the latest filed on Nov 30, 2023.
A track record needs three past buys with six months of prices behind them; Michael King has 0, so none is measured yet.
The newest scored trade: bought $4,500 of SABS on Nov 30, 2023, filed Nov 30, 2023, scored 45 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SABS: SAB Biotherapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | SAB Biotherapeutics, Inc. | $4,500 5,000 shares | - | - |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | SABS SAB Biotherapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +115,000 | $0.00 | $0 | 115,000 | Feb 23, 2024 |
| Nov 30, 2023 | SABS SAB Biotherapeutics, Inc. | POpen-market purchase Common Stock | +5,000 | $0.90 | $4,500 | 5,000 | Nov 30, 2023 |
| Oct 30, 2023 | SABS SAB Biotherapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +850,000 | $0.00 | $0 | 850,000 | Nov 3, 2023 |
Questions about Michael King
Answered from the filings on this page, as of the latest one.
Is Michael King buying or selling?
Not in the last 12 months. Michael King's latest open-market trade on SEC Form 4 was bought $4,500 of SABS on Nov 30, 2023.
How did Michael King's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael King has 0.
Where does Michael King file Form 4?
Michael King has filed Form 4 at SABS (SAB Biotherapeutics, Inc.) as CHIEF FINANCIAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.